{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:20:44Z","timestamp":1773282044212,"version":"3.50.1"},"reference-count":112,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ocular Immunology and Inflammation"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1080\/092739490500192","type":"journal-article","created":{"date-parts":[[2004,9,20]],"date-time":"2004-09-20T13:09:45Z","timestamp":1095685785000},"page":"169-192","source":"Crossref","is-referenced-by-count":61,"title":["A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation"],"prefix":"10.1080","volume":"12","author":[{"given":"Paul","family":"Gaudio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"key":"CIT0001","first-page":"5","volume":"65","author":"Bailey JM","year":"1989","journal-title":"Bull NY Acad Med"},{"key":"CIT0002","first-page":"131","volume":"251","author":"Talar-Williams C","year":"1994","journal-title":"Complications of corticosteroid therapy. Eur Arch Otorhinolaryngol"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/00002018-199308050-00004","volume":"8","author":"Hugues FC","year":"1993","journal-title":"An update. Drug Saf"},{"key":"CIT0005","first-page":"33","volume":"25","author":"McGhee CN","year":"2002","journal-title":"Danesh-Meyer H. Locally administered ocular corticosteroids: benefits and risks. Drug Saf"},{"key":"CIT0006","first-page":"48","volume":"7","author":"Kara-Jose N","year":"1972","journal-title":"Time response effects of corticosteroids on corneal wound healing. Can J Ophthalmol"},{"key":"CIT0008","first-page":"630","volume":"14","author":"Ho PC","year":"1975","journal-title":"II. Epidermal growth factor and topical corticosteroids. Invest Ophthalmol"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.66.11.705"},{"key":"CIT0010","first-page":"238","volume":"17","author":"Singh G","year":"1985","journal-title":"Ann Ophthalmol"},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/bjo.68.5.329","volume":"68","author":"Wakakura M","year":"1984","journal-title":"Br J Ophthalmol"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0002-9394(74)90448-6","volume":"77","author":"Martins JC","year":"1974","journal-title":"Corticosteroid-induced uveitis. Am J Ophthalmol"},{"key":"CIT0013","first-page":"883","volume":"70","author":"Krupin T","year":"1970","journal-title":"Uveitis in association with topically administered corticosteroid. Am J Ophthalmol"},{"key":"CIT0014","first-page":"424","volume":"10","author":"Newsome DA","year":"1971","journal-title":"Invest Ophthalmol"},{"key":"CIT0015","first-page":"776","volume":"75","author":"Armaly ME Dexamethasone ocular hypertension in the clinically normal eye","year":"1966","journal-title":"The untreated eye, outflow facility, and concentration. Arch Ophthalmol"},{"key":"CIT0017","first-page":"29","volume":"13","author":"Donshik PC","year":"1981","journal-title":"Ann Ophthalmol"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.76.11.681"},{"key":"CIT0024","first-page":"67","volume":"2","author":"Lee V-HL","year":"1986","journal-title":"JR. Topical ocular drug delivery: recent developments and future challenges. J Ocular Pharmacol"},{"key":"CIT0025","first-page":"483","volume":"7","author":"Watsky MA","year":"1988","journal-title":"Comparison of conjunctival and corneal surface areas in rabbit and human. Curr Eye Res"},{"key":"CIT0026","first-page":"308","volume":"88","author":"Cox WV","year":"1972","journal-title":"Topically applied steroids in corneal disease. I. The role of inflammation in stromal absorption of dexamethasone. Arch Ophthalmol"},{"key":"CIT0027","first-page":"78","volume":"79","author":"Leibowitz HM","year":"1974","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"CIT0028","first-page":"312","volume":"92","author":"Krupin T","year":"1974","journal-title":"Ocular penetration in rabbits of topically applied dexamethasone. Arch Ophthalmol"},{"key":"CIT0029","first-page":"453","volume":"24","author":"Bodker FS","year":"1993","journal-title":"Ophthalmic Surg"},{"key":"CIT0030","first-page":"89","volume":"565","author":"Musson DG","year":"1991","journal-title":"Assay methodology for prednisolone, prednisolone acetate and prednisolone sodium phosphate in rabbit aqueous humor and ocular physiological solutions. J Chromatogr"},{"key":"CIT0031","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2165\/00003088-199019020-00003","volume":"19","author":"Frey BM","year":"1990","journal-title":"Clin Pharmacokinet"},{"key":"CIT0032","first-page":"139","volume":"8","author":"Musson DG","year":"1992","journal-title":"An in vitro comparison of the permeability of prednisolone, prednisolone sodium phosphate, and prednisolone acetate across the NZW rabbit cornea. J Ocular Pharmacol"},{"key":"CIT0033","unstructured":"Smith RE, Nozik RA. Uveitis: a clinical approach to diagnosis and management. 2nd ed. Baltimore: Williams and Wilkins, 1989."},{"key":"CIT0035","first-page":"549","volume":"88","author":"Cox WV","year":"1972","journal-title":"Topically applied steroids in corneal disease. II. The role of drug vehicle in stromal absorption of dexamethasone. Arch Ophthalmol"},{"key":"CIT0036","first-page":"373","volume":"91","author":"Kupferman A","year":"1974","journal-title":"3. The role of drug derivative in stromal absorption of dexamethasone. Arch Ophthalmol"},{"key":"CIT0037","first-page":"377","volume":"91","author":"Kupferman A","year":"1974","journal-title":"IV. The role of drug concentration in stromal absorption of prednisolone acetate. Arch Ophthalmol"},{"key":"CIT0038","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archopht.1974.01010010339016","volume":"92","author":"Kupferman A","year":"1974","journal-title":"V. Dexamethasone alcohol. Arch Ophthalmol"},{"key":"CIT0039","first-page":"331","volume":"92","author":"Kupferman A","year":"1974","journal-title":"VI. Kinetics of prednisolone sodium phosphate. Arch Ophthalmol"},{"key":"CIT0040","first-page":"175","volume":"7","author":"Musson DG","year":"1991","journal-title":"Comparative corneal penetration of prednisolone sodium phosphate and prednisolone acetate in NZW rabbits. J Ocular Pharmacol"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1975.01010020439008"},{"key":"CIT0043","first-page":"339","volume":"19","author":"Yamauchi H","year":"1975","journal-title":"Jpn J Ophthalmol"},{"key":"CIT0045","first-page":"757","volume":"13","author":"Leibowitz HM","year":"1974","journal-title":"Invest Ophthalmol"},{"key":"CIT0046","first-page":"1387","volume":"94","author":"Leibowitz HM","year":"1976","journal-title":"Optimal concentration for treatment of inflammatory keratitis. Arch Ophthalmol"},{"key":"CIT0047","first-page":"61","volume":"18","author":"Schoenwald RD","year":"1979","journal-title":"Invest Ophthalmol Vis ScL"},{"key":"CIT0048","first-page":"2028","volume":"99","author":"Kupferman A","year":"1981","journal-title":"Prolongation of anti-inflammatory effect of prednisolone acetate. Influence of formulation in high-viscosity gel. Arch Ophthalmol"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600690407"},{"key":"CIT0050","first-page":"5","volume":"4","author":"Bisrat M","year":"1992","journal-title":"Acta Pharmacol Nord"},{"key":"CIT0051","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1001\/archopht.1979.01020020472014","volume":"97","author":"Leibowitz HM","year":"1979","journal-title":"Arch Ophthalmol"},{"key":"CIT0052","first-page":"703","volume":"116","author":"Fiscella RG","year":"1998","journal-title":"Generic prednisolone suspension substitution. Arch Ophthalmol"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1968.03850040176013"},{"key":"CIT0055","first-page":"247","volume":"84","author":"Romano PE","year":"1977","journal-title":"Fluorinated corticosteroid toxicity in infants. Am J Ophthalmol"},{"key":"CIT0056","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0002-9394(00)00501-8","volume":"130","author":"Ozerdem U","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"CIT0057","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/eye.1989.69","volume":"3","author":"McGhee CN","year":"1989","journal-title":"Eye"},{"key":"CIT0058","first-page":"526","volume":"4","author":"McGhee CN","year":"1990","journal-title":"Penetration of synthetic corticosteroids into human aqueous humour. Eye"},{"key":"CIT0059","first-page":"603","volume":"4","author":"Watson DG","year":"1990","journal-title":"Penetration of topically applied betamethasone sodium phosphate into human aqueous humour. Eye"},{"key":"CIT0060","first-page":"8","volume":"3","author":"Watson DG","year":"1989","journal-title":"The analysis of corticosteroid acetates by gas chromatography\/ negative ion chemical ionization mass spectrometry. Rapid Commun Mass Spectrom"},{"key":"CIT0061","first-page":"290","volume":"4","author":"Burde RM","year":"1972","journal-title":"Ann Ophthalmol"},{"key":"CIT0062","first-page":"719","volume":"5","author":"Mustakallio A","year":"1973","journal-title":"Ann Ophthalmol"},{"key":"CIT0063","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0002-9394(76)90071-4","volume":"82","author":"Corboy JM","year":"1976","journal-title":"Am J Ophthalmol"},{"key":"CIT0064","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/bjo.63.11.762","volume":"63","author":"Dunne JA","year":"1979","journal-title":"Br J Ophthalmol"},{"key":"CIT0065","first-page":"43","volume":"64","author":"Ramsell TG","year":"1980","journal-title":"Walker SR. Clinical evaluation of clobetasone butyrate: a comparative study of its effects in postoperative inflammation and on intraocular pressure. Br J Ophthalmol"},{"key":"CIT0067","first-page":"537","volume":"127","author":"Anonymous","year":"1999","journal-title":"Loteprednol Etabonate US Uveitis Study Group. Am J Ophthalmol"},{"key":"CIT0068","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0002-9394(14)72008-2","volume":"122","author":"Foster CS","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"CIT0069","first-page":"597","volume":"127","author":"Whitcup SM","year":"1999","journal-title":"New corticosteroids for the treatment of ocular inflammation. Am J Ophthalmol"},{"key":"CIT0070","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/archopht.1959.00940090747011","volume":"61","author":"Elliot AJ","year":"1959","journal-title":"Arch Ophthalmol"},{"key":"CIT0071","first-page":"694","volume":"76","author":"Nozik RA","year":"1972","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"CIT0072","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archopht.1969.00990020261021","volume":"82","author":"Hyndiuk RA","year":"1969","journal-title":"II. Subconjunctival administration. Arch Ophthalmol"},{"key":"CIT0073","first-page":"673","volume":"125","author":"Weijtens","year":"1998","journal-title":"Dexamethasone concentration in vitreous and serum after oral administration. Am J Ophthalmol"},{"key":"CIT0074","first-page":"192","volume":"128","author":"Weijtens","year":"1999","journal-title":"High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection. Am J Ophthalmol"},{"key":"CIT0076","first-page":"1932","volume":"107","author":"Weijtens","year":"2000","journal-title":"Dexamethasone concentration in the subretinal fluid after a subconjunctival injection, a peribulbar injection, or an oral dose. Ophthalmology"},{"key":"CIT0077","first-page":"635","volume":"51","author":"Kunou N","year":"2000","journal-title":"Biodegradable scleral implant for controlled intraocular delivery of betamethasone phosphate. J Biomed Mater Res"},{"key":"CIT0078","first-page":"297","volume":"76","author":"McCartney HJ","year":"1965","journal-title":"Invest Ophthalmol"},{"key":"CIT0080","first-page":"337","volume":"75","author":"Hakin KN","year":"1991","journal-title":"Use of orbital floor steroids in the management of patients with uniocular non-necrotising scleritis. Br J Ophthalmol"},{"key":"CIT0081","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0140-6736(61)90636-5","volume":"2","author":"Gebertt S","year":"1961","journal-title":"Lancet"},{"key":"CIT0082","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/bjo.49.6.298","volume":"49","author":"Rodger FC","year":"1965","journal-title":"Br J Ophthalmol"},{"issue":"120","key":"CIT0083","first-page":"125","volume":"22","author":"Schlaegel Jr TF, Weber JC.","year":"1977","journal-title":"II. Corticosteroids. Surv Ophthalmol"},{"key":"CIT0084","first-page":"66","volume":"8","author":"Riordan-Eva P","year":"1994","journal-title":"Orbital floor steroid injections in the treatment of uveitis. Eye"},{"key":"CIT0085","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/eye.1991.46","volume":"5","author":"Lightman S","year":"1991","journal-title":"Eye"},{"key":"CIT0086","first-page":"679","volume":"12","author":"Tanner V","year":"1998","journal-title":"Posterior sub-Tenon's triamcinolone injections in the treatment of uveitis. Eye"},{"key":"CIT0087","first-page":"171","volume":"19","author":"Walton RC","year":"1999","journal-title":"Sub-tenon's corticosteroids for the treatment of macular edema in bone marrow transplant retinopathy. Retina"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)73759-6"},{"key":"CIT0089","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/eye.1999.205","volume":"13","author":"Sajnani D","year":"1999","journal-title":"Eye"},{"key":"CIT0090","first-page":"867","volume":"113","author":"Kalina PH","year":"1995","journal-title":"Biochemical quantification of triamcinolone in subconjunctival depots. Arch Ophthalmol"},{"key":"CIT0091","first-page":"1884","volume":"103","author":"Francis BA","year":"1996","journal-title":"Particle size and drug interactions of injectable corticosteroids used in ophthalmic practice. Ophthalmology"},{"key":"CIT0092","first-page":"499","volume":"80","author":"Hyndiuk RA","year":"1968","journal-title":"I. Retrobulbar and systemic administration. Arch Ophthalmol"},{"key":"CIT0093","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/archopht.1970.00990030599015","volume":"83","author":"Levine ND","year":"1970","journal-title":"Arch Ophthalmol"},{"key":"CIT0094","first-page":"385","volume":"32","author":"Jennings T","year":"1988","journal-title":"Posterior sub-tenon's injections of corticosteroids in uveitis patients with cystoid macular edema. Jpn J Ophthalmol"},{"key":"CIT0095","first-page":"2003","volume":"104","author":"Thach AB","year":"1997","journal-title":"A comparison of retrobulbar versus sub-tenon's corticosteroid therapy for cystoid macular edema refractory to topical medications. Ophthalmology"},{"key":"CIT0096","first-page":"281","volume":"103","author":"Freeman WR","year":"1987","journal-title":"Echographic localization of corticosteroids after periocular injection. Am J Ophthalmol"},{"key":"CIT0097","first-page":"1893","volume":"36","author":"Olsen TW","year":"1995","journal-title":"Invest Ophthalmol Vis ScL"},{"key":"CIT0098","first-page":"660","volume":"95","author":"Morgan CM","year":"1988","journal-title":"Ocular complications associated with retrobulbar injections. Ophthalmology"},{"key":"CIT0099","first-page":"3569","volume":"41","author":"Jaffe GJ","year":"2000","journal-title":"Invest Ophthalmol Vis ScL"},{"key":"CIT0100","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(76)90669-3"},{"key":"CIT0101","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0002-9394(01)01372-1","volume":"133","author":"Levin DS","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"CIT0102","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0002-9394(99)80085-3","volume":"125","author":"Mueller AJ","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"CIT0103","first-page":"416","volume":"91","author":"Peyman GA","year":"1974","journal-title":"Treatment with intraocular injection of gentamicin and dexamethasone. Arch Ophthalmol"},{"key":"CIT0104","first-page":"149","volume":"92","author":"Graham RO","year":"1974","journal-title":"Treatment of experimentally induced endophthalmitis. Arch Ophthalmol"},{"key":"CIT0105","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S0161-6420(91)32108-0","volume":"98","author":"Maxwell Jr DP, Brent BD, Diamond JG, Wu L.","year":"1991","journal-title":"Ophthalmology"},{"key":"CIT0106","first-page":"1050","volume":"82","author":"Das T","year":"1999","journal-title":"Naduvilath TJ. Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study. Br J Ophthalmol"},{"key":"CIT0107","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0161-6420(99)00139-6","volume":"107","author":"Shah GK","year":"2000","journal-title":"Ophthalmology"},{"key":"CIT0108","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/eye.1999.179","volume":"13","author":"Majji AB","year":"1999","journal-title":"Eye"},{"key":"CIT0109","first-page":"1479","volume":"113","author":"Anonymous","year":"1995","journal-title":"A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group [see comments]. Arch Ophthalmol"},{"key":"CIT0110","first-page":"661","volume":"76","author":"Benitez Del Castillo Sanchez JM, Garcia Sanchez J.","year":"2001","journal-title":"Arch Soc Esp Oftalmol"},{"key":"CIT0111","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0161-6420(00)00466-8","volume":"107","author":"Jaffe GJ","year":"2000","journal-title":"Ophthalmology"},{"key":"CIT0113","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0161-6420(99)90060-X","volume":"106","author":"Tan DT","year":"1999","journal-title":"Ophthalmology"},{"key":"CIT0115","first-page":"402","volume":"20","author":"Jaffe GJ","year":"2000","journal-title":"Dexamethasone sustained drug delivery implant for the treatment of severe uveitis. Retina"},{"key":"CIT0117","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1442-9071.2001.00360.x","volume":"29","author":"Young S","year":"2001","journal-title":"Clin Exp Ophthalmol"},{"key":"CIT0118","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(00)00658-8"},{"key":"CIT0119","first-page":"1380","volume":"119","author":"Martidis A","year":"2001","journal-title":"Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Arch Ophthalmol"},{"key":"CIT0120","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0002-9394(82)90130-1","volume":"93","author":"Schindler RH","year":"1982","journal-title":"Am J Ophthalmol"},{"key":"CIT0121","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archopht.1992.01080140115038","volume":"110","author":"Kwak HW","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"CIT0122","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/0002-9394(50)91827-7","volume":"33","author":"Woods AC","year":"1950","journal-title":"Am J Ophthalmol"},{"key":"CIT0123","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0002-9394(56)91653-1","volume":"41","author":"Gordon DM","year":"1956","journal-title":"Am J Ophthalmol"},{"key":"CIT0124","first-page":"273","volume":"1","author":"Solomon SD","year":"2000","journal-title":"Compr Ophthalmol Update"},{"key":"CIT0125","first-page":"847","volume":"104","author":"Wakefield D","year":"1986","journal-title":"Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease. Arch Ophthalmol"},{"key":"CIT0126","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archopht.1987.01060060079037","volume":"105","author":"McCluskey P","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"CIT0127","first-page":"420","volume":"5","author":"Hill JC","year":"1991","journal-title":"Watson PG. The use of a single pulse of intravenous methylprednisolone in the treatment of corneal graft rejection: a preliminary report. Eye"},{"key":"CIT0128","first-page":"48","volume":"21","author":"Behar-Cohen FF","year":"2001","journal-title":"Methylprednisolone concentrations in the vitreous and the serum after pulse therapy. Retina"},{"key":"CIT0129","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0002-9394(61)90456-1","volume":"52","author":"Kroman HS","year":"1960","journal-title":"Am J Ophthalmol"},{"key":"CIT0130","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/bjo.82.6.704","volume":"82","author":"Stanbury R","year":"1998","journal-title":"Br J Ophthalmol"}],"container-title":["Ocular Immunology and Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/092739490500192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T06:17:20Z","timestamp":1497593840000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/092739490500192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":112,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,7,8]]},"published-print":{"date-parts":[[2004,1]]}},"alternative-id":["10.1080\/092739490500192"],"URL":"https:\/\/doi.org\/10.1080\/092739490500192","relation":{},"ISSN":["0927-3948","1744-5078"],"issn-type":[{"value":"0927-3948","type":"print"},{"value":"1744-5078","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}